BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17805030)

  • 1. Molecular pathology and epidemiology of nephrogenic rests and Wilms tumors.
    Fukuzawa R; Reeve AE
    J Pediatr Hematol Oncol; 2007 Sep; 29(9):589-94. PubMed ID: 17805030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wilms tumour histology is determined by distinct types of precursor lesions and not epigenetic changes.
    Fukuzawa R; Anaka MR; Heathcott RW; McNoe LA; Morison IM; Perlman EJ; Reeve AE
    J Pathol; 2008 Aug; 215(4):377-87. PubMed ID: 18484682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic differences between Wilms' tumours in white and east-Asian children.
    Fukuzawa R; Breslow NE; Morison IM; Dwyer P; Kusafuka T; Kobayashi Y; Becroft DM; Beckwith JB; Perlman EJ; Reeve AE
    Lancet; 2004 Feb; 363(9407):446-51. PubMed ID: 14962525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor.
    Breslow NE; Beckwith JB; Perlman EJ; Reeve AE
    Pediatr Blood Cancer; 2006 Sep; 47(3):260-7. PubMed ID: 16700047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor.
    Beckwith JB; Kiviat NB; Bonadio JF
    Pediatr Pathol; 1990; 10(1-2):1-36. PubMed ID: 2156243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perilobar nephrogenic rests are nonobligate molecular genetic precursor lesions of insulin-like growth factor-II-associated Wilms tumors.
    Vuononvirta R; Sebire NJ; Dallosso AR; Reis-Filho JS; Williams RD; Mackay A; Fenwick K; Grigoriadis A; Ashworth A; Pritchard-Jones K; Brown KW; Vujanic GM; Jones C
    Clin Cancer Res; 2008 Dec; 14(23):7635-44. PubMed ID: 19047088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrogenic rests in Wilms tumors treated with preoperative chemotherapy: The UK SIOP Wilms Tumor 2001 Trial experience.
    Vujanić GM; Apps JR; Moroz V; Ceroni F; Williams RD; Sebire NJ; Pritchard-Jones K
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28383760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations.
    Beckwith JB
    Am J Med Genet; 1998 Oct; 79(4):268-73. PubMed ID: 9781906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
    Charles AK; Brown KW; Berry PJ
    Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelotyping nephrogenic rests: putative precursor lesions of Wilms tumors.
    Maitra A; Salahuddin S; Timmons CF; Gazdar AF
    Pediatr Dev Pathol; 1999; 2(5):488-9. PubMed ID: 10441628
    [No Abstract]   [Full Text] [Related]  

  • 11. Precursor lesions of Wilms tumor: clinical and biological implications.
    Beckwith JB
    Med Pediatr Oncol; 1993; 21(3):158-68. PubMed ID: 8383276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephrogenic rests in Wilms tumor patients with the Drash syndrome.
    Heppe RK; Koyle MA; Beckwith JB
    J Urol; 1991 Jun; 145(6):1225-8. PubMed ID: 1851891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging Characteristics of Nephrogenic Rests Versus Small Wilms Tumors: A Report From the Children's Oncology Group Study AREN03B2.
    Sandberg JK; Chi YY; Smith EA; Servaes S; Hoffer FA; Mullen EA; Perlman EJ; Tornwall B; Ehrlich PF; Geller JI; Grundy PE; Fernandez CV; Dome JS; Khanna G
    AJR Am J Roentgenol; 2020 May; 214(5):987-994. PubMed ID: 32160052
    [No Abstract]   [Full Text] [Related]  

  • 14. Epidemiologic features of Wilms tumor.
    Birch JM; Breslow N
    Hematol Oncol Clin North Am; 1995 Dec; 9(6):1157-78. PubMed ID: 8591959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precursor lesions of Wilms' tumor in Indian children: a multiinstitutional study.
    Mishra K; Mathur M; Logani KB; Kakkar N; Krishna A
    Cancer; 1998 Nov; 83(10):2228-32. PubMed ID: 9827730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor II messenger ribonucleic acid expression in Wilms tumor, nephrogenic rest, and kidney.
    Yun K; Molenaar AJ; Fiedler AM; Mark AJ; Eccles MR; Becroft DM; Reeve AE
    Lab Invest; 1993 Nov; 69(5):603-15. PubMed ID: 7504120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imprinting, expression, and localisation of DLK1 in Wilms tumours.
    Fukuzawa R; Heathcott RW; Morison IM; Reeve AE
    J Clin Pathol; 2005 Feb; 58(2):145-50. PubMed ID: 15677533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic features of nephrogenic rests and nephroblastomatosis.
    Hennigar RA; O'Shea PA; Grattan-Smith JD
    Adv Anat Pathol; 2001 Sep; 8(5):276-89. PubMed ID: 11556536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of H19, an imprinted and putative tumor repressor gene, is a preneoplastic event during Wilms' tumorigenesis.
    Cui H; Hedborg F; He L; Nordenskjöld A; Sandstedt B; Pfeifer-Ohlsson S; Ohlsson R
    Cancer Res; 1997 Oct; 57(20):4469-73. PubMed ID: 9377554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the RNA component of telomerase in Wilms tumor and nephrogenic rest recapitulates renal embryogenesis.
    Yashima K; Maitra A; Timmons CF; Rogers BB; Pinar H; Shay JW; Gazdar AF
    Hum Pathol; 1998 May; 29(5):536-42. PubMed ID: 9596280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.